GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Sonoma Pharmaceuticals
Sonoma Pharmaceuticals produces dermatological and ophthalmic products based on hypochlorous acid. Its stock price reflects its struggle to secure market share and expand the application of its technology.
Share prices of companies in the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and ophthalmology. We've categorized it under "Pharma: Skin." The chart below shows how the market values companies in the advanced skin care sector.
Broad Market Index - GURU.Markets
Sonoma Pharmaceuticals produces and sells hypochlorous acid (HOCl) for use in dermatology, wound care, and ophthalmology. It is a component of the GURU.Markets index. The chart below shows the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
SNOA - Daily change in the company's share price Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc.'s daily stock price fluctuates reflecting the volatility of the medical device sector. The metric demonstrates sensitivity to sales of its hypochlorous acid-based wound care and dermatology products.
Daily change in the price of a set of shares in a market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based products for wound and skin care. The dermatology and wound care segment is stable but competitive. The chart below shows the average volatility in this niche, allowing you to compare SNOA's performance with other companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Sonoma Pharmaceuticals produces hypochlorous acid-based products for wound and skin care. The company's stock price reflects consumer health trends and competition in the pharmacy market. These fluctuations are part of the overall picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Sonoma Pharmaceuticals
For Sonoma Pharmaceuticals, year-over-year performance is the story of its hypochlorous acid-based products. Its market capitalization over the past 12 months reflects its success in selling its wound, eye, and skin care products, as well as its strategy to license its technology to other companies worldwide.
Annual dynamics of market capitalization of the market segment - Pharma skin
Sonoma, a commercial pharmaceutical company, focuses on wound care and dermatology products. This chart shows how its niche strategy, competition, and sales growth efforts impact its volatile performance in the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sonoma Pharmaceuticals specializes in wound care and dermatology products based on Microcyn technology. Its year-over-year market capitalization reflects how successfully the company is commercializing its platform and competing with traditional antiseptics. It's a story of how one technology can find multiple applications.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Sonoma Pharmaceuticals
Sonoma Pharmaceuticals is a manufacturer of hypochlorous acid-based products for wound care and dermatology. Its monthly sales reflect sales of its own brands and through partners.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and animal health. This is a niche technology. The company's success depends on expanding distribution and product recognition. The pharmaceutical sector chart illustrates the general trends against which Sonoma is attempting to gain market share.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sonoma Pharmaceuticals produces dermatological and ophthalmological products based on hypochlorous acid. It is a niche pharmaceutical company. Its shares can move independently of the market, reacting to sales reports, distribution agreements, and news of product line expansion.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Sonoma Pharmaceuticals
Sonoma Pharmaceuticals produces hypochlorous acid-based products for wound care and dermatology. Its weekly stock price reflects sales volumes, news of new product approvals in various countries, and its ability to compete in the skincare market.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound and skin care. Its success depends on marketing and distribution in a competitive sector. The chart compares its weekly performance with other dermatology companies and reveals its market position.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Sonoma Pharmaceuticals produces wound and skin care products. Demand for its products is relatively stable. The chart helps assess how well the company's stock, thanks to its niche, is protected from the strong volatility seen in the broader stock market.
Market capitalization of the company, segment and market as a whole
SNOA - Market capitalization of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals' market capitalization is a measure of investor valuation of its hypochlorous acid-based technology. The chart shows how the market values its wound care, dermatology, and ophthalmology products. Its low valuation reflects the challenges of marketing and distributing its products in competitive medical markets.
SNOA - Share of the company's market capitalization Sonoma Pharmaceuticals within the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care and dermatology. Its market share in the pharmaceutical sector is small, but it is a leader in its niche. Its market capitalization reflects the value of its patented Microcyn technology for safe disinfection.
Market capitalization of the market segment - Pharma skin
Below is a graph showing the total value of the entire pharmaceutical sector focused on skin care. For Sonoma Pharmaceuticals, with its hypochlorous acid-based products, this line represents a map of medical needs. The rising graph reflects the demand for safe and effective solutions for wound care and the treatment of skin conditions.
Market capitalization of all companies included in a broad market index - GURU.Markets
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care and dermatology. Its market capitalization reflects its unique medical technology. This represents the market share of businesses using safe antiseptics.
Book value capitalization of the company, segment and market as a whole
SNOA - Book value capitalization of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals produces wound care and dermatology products based on Microcyn technology. Its book value is derived from its manufacturing capacity, patents, and finished product inventory. This is the material foundation for skin health. How has this changed? The chart below shows.
SNOA - Share of the company's book capitalization Sonoma Pharmaceuticals within the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures hypochlorous acid-based products. Its business relies on its own manufacturing facilities in the US and Europe, where it produces medical and consumer products. The chart shows the company's share of the physical infrastructure for the production of specialty medicinal chemicals.
Market segment balance sheet capitalization - Pharma skin
Sonoma Pharmaceuticals is a pharmaceutical company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. As a commercial company, Sonoma invests not only in R&D but also in the infrastructure to market its products.
Book value of all companies included in the broad market index - GURU.Markets
Sonoma Pharmaceuticals' assets include manufacturing facilities for wound care and dermatological products based on stabilized hypochlorous acid. Its book value reflects its industrial potential in this niche medical area. The chart shows its weighting.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Sonoma Pharmaceuticals
Sonoma Pharmaceuticals produces dermatological and ophthalmological products based on hypochlorous acid. Its market capitalization is based on its patented technology and its application in various medical niches.
Market to book capitalization ratio in a market segment - Pharma skin
Sonoma Pharmaceuticals produces hypochlorous acid-based products for wound and skin care. It's a niche medical business. The chart shows how investors view its patented technology and its ability to expand the use of its products.
Market to book capitalization ratio for the market as a whole
Sonoma Pharmaceuticals produces hypochlorous acid-based medications for wound care and dermatology. The company has actual production and approved products. This chart compares the valuation of a stable healthcare company with overall market trends, which are often dominated by expectations of future breakthroughs.
Debts of the company, segment and market as a whole
SNOA - Company debts Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, a company that produces wound care and dermatology products based on Microcyn technology, uses capital to fund its sales and marketing. This chart illustrates the financial realities of a small healthcare company seeking to expand its product presence in a competitive market.
Market segment debts - Pharma skin
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid (HOCl)-based products for wound care, dermatology, and eye care. This chart illustrates how the company, with its unique technology platform, manages its capital to fund marketing and expand the use of its products across various medical fields.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Sonoma Pharmaceuticals
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care and dermatology. To compete in the medical device market, the company must invest in manufacturing, marketing, and clinical research. This chart shows how it uses debt to finance its commercial activities.
Market segment debt to market segment book capitalization - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care and dermatology. This chart shows how the small pharmaceutical company finances its production and marketing. It compares its debt load to the market capitalization of the entire pharmaceutical sector, reflecting its financial strategy.
Debt to book value of all companies in the market
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care and dermatology. The medical and consumer markets require marketing and distribution costs. Does the company use debt to expand its presence? This chart of total market debt helps evaluate its financial strategy.
P/E of the company, segment and market as a whole
P/E - Sonoma Pharmaceuticals
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and animal health. This chart shows how investors value the company in niche medical markets. The valuation depends on sales growth and expansion of the company's distribution network.
P/E of the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and ophthalmology. This chart illustrates the average rating in the dermatology pharmaceutical sector, where the efficacy and safety of topical products are critical.
P/E of the market as a whole
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid (HOCl)-based products for wound care, dermatology, and animal health. This chart reflects general trends in the healthcare sector. It helps understand how the market values Sonoma's niche products against the overall sentiment in the pharmaceutical and medical industries.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals manufactures and markets products based on Microcyn technology for wound care, dermatology, and ophthalmology. The company's success depends on the widespread use of its hypochlorous acid in medicine. This chart shows how the market views the future sales and expansion of the company's products across various medical fields.
%20P%2FE%20Sonoma%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Sonoma-Pharmaceuticals&v=1772650219576 "Chart of the company's future (projected) P/E Sonoma Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and ophthalmology. The chart compares Sonoma's future profitability expectations with those of the industry. It helps understand the market's confidence in the effectiveness of its core technology and the company's ability to expand its application.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772650219615 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and ophthalmology. It is a niche pharmaceutical company. This chart of overall healthcare sentiment helps understand how investors view the prospects of companies with specialized and proven products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772650219621 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and animal health. Profits are driven by sales of these specialized medical products. This chart shows the financial performance of the company, which has found its niche in disinfection and healing.
Profit of companies in the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based products for wound care, dermatology, and ophthalmology. This technology is safe and effective. This chart shows the overall profitability of the dermatology pharmaceutical sector, where innovative and safe skin care and wound treatment solutions are always in demand.
Overall market profit
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based medications for wound care, dermatology, and ophthalmology. Demand for its products is driven by medical needs and is stable. This business falls within the protective healthcare sector and is not affected by general economic cycles, as can be seen in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and eye care. Future profits depend on sales growth of its own and partner brands. This chart reflects analyst expectations for its niche technology.
%20profit%20of%20the%20company%20Sonoma%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Sonoma-Pharmaceuticals&v=1772650219736 "Graph of future (projected) profit of the company Sonoma Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and animal health. This technology provides effective and safe disinfection. This chart shows revenue projections for the dermatology segment, providing context for evaluating Sonoma's niche products.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772650219749 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based products for wound care and dermatology. Demand for its products is driven by healthcare spending. This economic outlook impacts healthcare budgets and consumers' ability to afford medical products.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772650219777 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Sonoma Pharmaceuticals
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and eye care. Revenue is driven by sales of these specialized medical devices. This chart shows how investors value its patented technology and its applications in various medical fields.
P/S market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and ophthalmology. Their technology provides safe and effective antimicrobial action. This chart shows the average revenue estimate for the sector, helping to assess how the market values Sonoma's niche pharmaceutical products.
P/S of the market as a whole
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based medications for wound care, dermatology, and ophthalmology. This graph, showing average revenue estimates, allows us to assess how the market views this company, with its proven but niche healthcare technology, compared to larger pharmaceutical players.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and commercializes products based on its Microcyn technology, which is used in wound care, dermatology, and animal health. Its revenue valuation is important to the company, as it reflects investors' assessment of its ability to expand the application of its platform technology and grow sales across various medical and consumer markets.
%20P%2FS%20Sonoma%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Sonoma-Pharmaceuticals&v=1772650219865 "The graph of the company's future (projected) P/S Sonoma Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and animal health. This chart reflects how investors view the company's future earnings relative to the pharmaceutical sector. It demonstrates the market's confidence in the effectiveness of its hypochlorous acid for disinfection and healing, and its ability to expand the application of its technology.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772650219875 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and animal health. The company's success depends on its ability to compete in the medical device market. This graph of investor expectations reflects their view of the healthcare sector and the demand for effective treatments and care products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772650219897 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Sonoma Pharmaceuticals
This chart shows Sonoma Pharmaceuticals' revenue from sales of its Microcyn technology-based products for wound care, dermatology, and ophthalmology. Revenue growth is driven by the expansion of its distribution network and demand for its safe and effective antiseptic and disinfectant products.
Sales of companies in the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and animal health. Its sales breakdown by segment (direct sales, partnerships) and region demonstrates where its unique technology is most widely used and commercially successful.
Overall market sales
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and ophthalmology. The company operates in the non-cyclical healthcare sector. This general economic activity pattern has little impact on demand for the effective and safe medical products Sonoma offers.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and eye care. Sales growth depends on expanded distribution and acceptance by the medical community. This chart shows analysts' expectations for demand for its unique antiseptic and healing products.
%20sales%20of%20the%20company%20Sonoma%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Sonoma-Pharmaceuticals&v=1772650219967 "Schedule of future (projected) sales of the company Sonoma Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma skin
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based products for wound care and dermatology. This chart shows the sales forecast for the entire dermatology market. Is demand for effective and safe skin treatments growing? This reflects the overall potential of this segment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772650219994 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and animal health. Demand for wound care products is stable, but the dermatology segment can be more sensitive to economic cycles. This dynamic may impact consumer discretionary spending on skin care.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772650220030 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets stabilized hypochlorous acid-based products for wound care, dermatology, and eye care. This chart shows the company's success in commercializing its proprietary technology. Profitability depends on sales volume, partnerships, and expansion of its products into new markets.
Market segment marginality - Pharma skin
Sonoma Pharmaceuticals, Inc. develops and markets products based on its Microcyn® technology for wound care, dermatology, and ophthalmology. The company's profitability depends on sales volume, distribution efficiency, and partnerships. This metric reflects its commercial efforts in the medical device market.
Market marginality as a whole
Sonoma Pharmaceuticals produces hypochlorous acid-based products for wound care and dermatology. Its success depends on sales in the competitive healthcare market. This gross margin chart reflects the state of the healthcare system and consumer spending on healthcare products, which shape Sonoma's market environment.
Employees in the company, segment and market as a whole
Number of employees in the company Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets products based on Microcyn technology for wound care, dermatology, and animal health. Its staff includes manufacturing and sales personnel. This chart shows how the company manages its team to manufacture products and market them through various distribution channels worldwide.
Share of the company's employees Sonoma Pharmaceuticals within the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets wound care and dermatological products based on its proprietary Microcyn technology. Production and commercialization require both manufacturing personnel and a sales team. This graph shows the company's market share, reflecting its manufacturing and commercial scale in the medical device niche.
Number of employees in the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based products for wound care, dermatology, and eye care. This chart shows employment in the dermatology pharmaceuticals sector. Sonoma's Microcyn technology provides effective and safe antimicrobial action without the use of antibiotics.
Number of employees in the market as a whole
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based products for wound care and dermatology. Its success depends on the acceptance of its products in the medical and consumer markets. This chart illustrates the overall picture, with Sonoma serving as an example of a niche healthcare company whose market growth is driven by the effectiveness of its technology.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals specializes in wound care and dermatology products based on their Microcyn technology. This chart shows how the market values their core technology. It reflects the market value per employee, which is a measure of the value of their IP and commercialized products.
%20of%20the%20company%20Sonoma%20Pharmaceuticals%20(SNOA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Sonoma-Pharmaceuticals-SNOA&v=1772650220252 "Chart of market capitalization per employee (in thousands of dollars) of the company Sonoma Pharmaceuticals (SNOA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Sonoma Pharmaceuticals (SNOA) develops and markets hypochlorous acid-based products for wound care, dermatology, and eye care. This metric for a healthcare company demonstrates the broad applicability of its core technology. Growth could indicate successful expansion into new markets or approvals for new applications.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772650220271 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Sonoma Pharmaceuticals produces hypochlorous acid-based products for wound care and dermatology. This indicator reflects the value of its patented technology. The market evaluates the company's ability to produce and sell effective and safe products, carving out a niche in the medical and consumer goods markets.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772650220283 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals develops and markets products based on Microcyn (hypochlorous acid) technology for wound care and dermatology. This chart shows how profitable this niche is. Revenue per employee here is the margin earned from sales of these specialized medical solutions and sprays.
%20Chart%20Sonoma%20Pharmaceuticals%20(SNOA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Sonoma-Pharmaceuticals-SNOA&v=1772650220289 "Company Profit Per Employee (in thousands of dollars) Chart Sonoma Pharmaceuticals (SNOA)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Sonoma Pharmaceuticals manufactures and markets hypochlorous acid-based medications for wound care and dermatology. In the medical products sector, productivity per employee depends on production and distribution. This chart shows how efficiently the company utilizes its resources to generate profit compared to its healthcare competitors.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772650220308 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Sonoma Pharmaceuticals is a company that produces wound care, dermatology, and ophthalmology products based on its proprietary Microcyn (hypochlorous acid) technology. It's a medtech/pharma company. This chart helps illustrate how profitable a business based on a proprietary chemistry platform and manufacturing process is per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772650220317 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals sells hypochlorous acid-based products for wound care and dermatology. This chart demonstrates the effectiveness of their commercial strategy. The increase in revenue per employee reflects expanded distribution, recognition of their products by the medical community, and the strength of their patented technology.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Sonoma-Pharmaceuticals-SNOA&v=1772650220332 "Sales chart per company employee Sonoma Pharmaceuticals (SNOA)")
Sales per employee in the market segment - Pharma skin
Sonoma Pharmaceuticals produces products based on Microcyn technology (hypochlorous acid) for wound care, dermatology, and eye care. This chart shows the average production in the sector. For SNOA, this is an indicator of how productive their manufacturing and commercial team are in selling these niche medical products.
Sales per employee for the market as a whole
Sonoma Pharmaceuticals has commercialized its Microcyn technology, selling products for wound care, dermatology, and ophthalmology. It is a commercial-stage company. This indicator demonstrates how effective their manufacturing and sales efforts are in promoting their niche medical products.
Short shares by company, segment and market as a whole
Shares shorted by company Sonoma Pharmaceuticals (SNOA)
Sonoma Pharma (SNOA) produces hypochlorous acid (HOCl)-based products for wound care and dermatology. This chart shows the number of short positions. Short sellers may believe the company's products lack clear advantages over cheaper antiseptics and question its growth strategy.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Sonoma-Pharmaceuticals-SNOA&v=1772650220435 "Short Shares Chart for the Company Sonoma Pharmaceuticals (SNOA)")
Shares shorted by market segment - Pharma skin
Sonoma Pharmaceuticals (SNOA) manufactures and markets hypochlorous acid (HOCl)-based products for wound care, dermatology, and eye care. This chart aggregates short positions in the biotech (dermatology) sector. It reflects investor skepticism about niche drugs and the high level of competition in this space.
Shares shorted by the overall market
Sonoma Pharmaceuticals sells dermatological and ophthalmic solutions. This chart illustrates the overall market pessimism. Although its products are medical, it competes with giants. During times of fear, investors may worry that the company won't have sufficient marketing budgets to maintain market share during a crisis.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals sells over-the-counter skin and eye care products (Microcyn). It's a commercial business, driven by sales. This indicator measures the "pulse" of their quarterly reports. It "warms up" if revenue growth exceeds expectations and "cools down" if sales stagnate.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Sonoma-Pharmaceuticals-SNOA&v=1772650220511 "RSI 14 indicator chart for the company's stock Sonoma Pharmaceuticals (SNOA)")
RSI 14 Market Segment - Pharma skin
Sonoma Pharmaceuticals (SNOA) produces products based on "super-oxidized" water (Microcyn technology) for wound care and dermatology. This chart tracks overall sentiment in the Pharma/Dermatology sector. It helps investors understand whether SNOA's performance reflects its niche or whether the entire industry is overheated or oversold.
RSI 14 for the overall market
For Sonoma Pharmaceuticals, a biotech company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the money supply is turned off, and companies burning through cash risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SNOA (Sonoma Pharmaceuticals)
Sonoma Pharmaceuticals specializes in wound care, dermatology, and ophthalmology products based on its proprietary Microcyn (hypochlorous acid) technology. This chart shows the average analyst price target, reflecting their view on sales growth for these products through distribution partnerships.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SNOA-Sonoma-Pharmaceuticals&v=1772650220557 "A chart showing analyst consensus forecasts for the expected stock price. SNOA (Sonoma Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price SNOA (Sonoma Pharmaceuticals)
Sonoma Pharma is the company behind Microcyn technology. It produces stabilized hypochlorous acid (HOCl) for wound care, dermatology, and eye care. This chart shows how the current share price differs from the "fair" value predicted by analysts, reflecting their faith in this niche technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SNOA-Sonoma-Pharmaceuticals&v=1772650220558 "A chart showing the difference between the consensus forecast and the actual stock price. SNOA (Sonoma Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Sonoma Pharma (SNOA) is a company that produces products based on chlorochlorous acid (HOCl), a powerful yet safe disinfectant for wound treatment and skin care. This chart shows general expectations for the skin pharmaceutical sector. It reflects whether experts believe the advanced wound care market will grow.
Analysts' consensus forecast for the overall market share price
Sonoma Pharmaceuticals produces products (Microcyn) based on "super-oxygenated" water (HOCl) for wound care, dermatology, and eye care. This chart shows overall market sentiment. For Sonoma, which operates in the "protective" healthcare sector, overall optimism is important, but their growth depends more on successful marketing of niche products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Sonoma Pharmaceuticals
Sonoma Pharmaceuticals is a MedTech veteran. Their signature product is Microcyn: stabilized hypochlorous acid (HOCl), which they market (under their own and other brands) as a super-antiseptic for wound treatment and skin care. This chart is a summary indicator of their turnaround history. It reflects their (low-margin) business and their struggle for profitability.
AKIMA Market Segment Index - Pharma skin
Sonoma Pharmaceuticals (SNOA) is built on its proprietary Microcyn (hypochlorous acid) technology. It's a super disinfectant that they use to create a wide range of products, from wound care sprays and acne treatments to Avenova eye drops. This chart shows the average index for the segment, which helps assess the success of this platform model.
The AKIM Index for the overall market
Sonoma Pharmaceuticals develops and markets hypochlorous acid-based dermatological products (for wound and infection treatment). This market average chart provides a macro backdrop. It helps assess how SNOA, a niche skincare player, compares to overall economic trends.
